| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 23.762 | 29.911 | 28.362 | 34.423 | 35.811 | 32.759 | 30.539 | 33.602 | 33.454 | 31.583 |
| Total Income - EUR | 23.805 | 29.914 | 28.361 | 34.430 | 35.815 | 32.764 | 30.542 | 33.756 | 33.511 | 31.632 |
| Total Expenses - EUR | 13.706 | 14.940 | 14.350 | 15.855 | 20.305 | 18.447 | 18.542 | 20.871 | 18.898 | 20.565 |
| Gross Profit/Loss - EUR | 10.099 | 14.974 | 14.011 | 18.575 | 15.510 | 14.317 | 12.000 | 12.886 | 14.614 | 11.067 |
| Net Profit/Loss - EUR | 9.385 | 14.376 | 13.727 | 18.233 | 15.151 | 14.085 | 11.897 | 12.612 | 14.329 | 10.261 |
| Employees | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 1 | 1 |
Check the financial reports for the company - Gaby Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 9.951 | 9.798 | 9.582 | 9.357 | 1.346 | 1.272 | 2.206 | 1.827 | 1.436 | 1.046 |
| Current Assets | 9.491 | 14.456 | 12.382 | 19.662 | 25.778 | 14.145 | 11.936 | 13.415 | 15.606 | 11.699 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 138 | 0 | 0 |
| Receivables | 1.685 | 1.905 | 1.563 | 3.751 | 3.070 | 0 | 3.031 | 9.870 | 6.358 | 0 |
| Cash | 7.807 | 12.551 | 10.818 | 15.911 | 22.707 | 14.145 | 8.904 | 3.407 | 9.248 | 11.699 |
| Shareholders Funds | 17.734 | 22.640 | 21.852 | 26.209 | 15.202 | 14.135 | 11.957 | 12.688 | 14.443 | 10.635 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.708 | 1.613 | 111 | 2.810 | 11.922 | 1.282 | 2.184 | 2.554 | 2.600 | 2.110 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Gaby Med Srl